INTRODUCTION
Psoriasis is one of the most common immune-mediated chronic inflammatory skin disorders characterized by hyperproliferative keratinocytes and massive infiltration of leukocytes (Schö n and Boehncke, 2005) . Although the pathogenesis of psoriasis is not fully understood, there is growing evidence that the interleukin-23 (IL-23)-T helper 17 (Th17) cell axis and Th17 cell-related cytokines play critical roles in disease development (Clark, 2010; Di Cesare et al., 2009; Zaba et al., 2009) .
Psoriatic skin lesions are reported to have increased gene and protein expression of IL-23, IL-21, IL-22, and IL-17 Caruso et al., 2009; Johansen et al., 2009; Lee et al., 2004) . IL-23-induced changes in mouse skin share many characteristics with human psoriasis, including erythematosus, hyperplasia of the epidermis (acanthosis), parakeratosis, and leukocyte infiltration (Chan et al., 2006) . The dermal inflammation and acanthosis induced by IL-23 are thought to be mediated by a Th17 cell cytokine, IL-22 (Zheng et al., 2007) , and the chemokine receptor CCR6 expression is required as well (Hedrick et al., 2009) . The importance of IL-23 is further demonstrated by the therapeutic efficacy of human mAb against the subunit of p40 of IL-12 and IL-23 in the treatment of psoriasis (Griffiths et al., 2010; Krueger et al., 2007) . IL-23-induced skin inflammation has primarily been linked to the function of Th17 cells and related cytokines (Di Cesare et al., 2009; Harper et al., 2009; Steinman, 2010; Zaba et al., 2009 ). Therefore, IL-23 and Th17 cells may be key mediators of disease pathogenesis (Blauvelt, 2008) . One caveat of these studies is that although elevated IL-17 and IL-22 production is observed in psoriatic skin (Harper et al., 2009; Lowes et al., 2008; Wilson et al., 2007; Zaba et al., 2007) , it is not presently known whether these cytokines, e.g., IL-17, are directly secreted by Th17 cells. Thus, the primary IL-17-producing cells responsive to IL-23 stimulation in skin remain to be determined. Furthermore, the pathogenic role of these cells that induce skin inflammation and acanthosis in psoriasis needs to be established. These issues are significant because psoriasis is currently considered to be a CD4 + Th17 cell-mediated disease (Di Cesare et al., 2009; Lowes et al., 2008; Steinman, 2010) . Murine epidermis contains large numbers of gd T cells (Hayday and Tigelaar, 2003) . These gd T cells have a marked dendritic morphology and have been named dendritic epidermal T cells (DETCs) (Havran and Jameson, 2010) . In addition, gd T cells exist in both human and murine dermis. In this study, we found that innate dermal gd T cells-but not epidermal gd T cells or dermal gd À T cells-were the major IL-17-producing cells in the skin after IL-23 stimulation. Deficiency of gd T cells or IL-17 receptor significantly decreased IL-23-induced epidermal thickness and neutrophil infiltration. This was also the case in the imiquimod (IMQ)-induced psoriasis-like model. Furthermore, IL-17-secreting gd T cells were present in high frequency in human psoriatic skin lesions. These observations support the idea that IL-17-producing dermal gd T cells are a key component in the pathogenesis of psoriasis.
RESULTS

IL-23 Is Mainly Produced by Dermal Dendritic Cells and Macrophages, which Is Critical for IL-17 Production in the Skin
IL-23 has been clearly linked to the pathogenesis of psoriasis (Chan et al., 2006) . Previous studies demonstrate that transcripts encoding IL-23p19 and IL-23p40 are increased during human psoriasis (Lee et al., 2004) . To dissect the cellular source of IL-23, skin tissues from healthy individuals and patients with psoriasis were analyzed by immunofluorescent staining. We found that IL-23p19 protein was colocalized with CD11c + dendritic cells (DCs) and CD68 + macrophages (Mf) ( Figure 1A ) (Gilliet et al., 2004; Rajan and Langtry, 2006) . IMQ topical treatment induced typical psoriasis-like manifestations including epidermal thickness, erythema, and inflammation (Figure 1B) . IL-23 and IL-17 mRNAs were increased in the lesional skin. Analysis of lesional skin sections by immunofluorescent staining with IL-23p19 mAb demonstrated that IL-23p19 protein was colocalized with DCs and Mf distributed throughout the dermis, suggesting that DCs and Mf are the predominant cells secreting IL-23 ( Figure 1C ). We further used whole skin cells or skin cells devoid of DCs and Mf to detect IL-23p19 transcripts in vitro upon IMQ stimulation. The IL-23p19 mRNA was increased in total skin cells after IMQ stimulation. However, it was decreased when skin cells were devoid of DCs and Mf ( Figure 1D ). IMQ stimulated high amounts of IL-23p19 mRNA on skin DCs and Mf. Finally, we examined whether IL-23 secreted by DCs and Mf was responsible for skin IL-17 production. Whole skin cells stimulated with IMQ produced high amount of IL-17 mRNA whereas skin cells devoid of DCs and Mf did not transcribe appreciable amounts of IL-17 mRNA ( Figure 1E ). These data suggest that IL-23 secreted by skin DCs and Mf is essential for IL-17 production in the skin.
Dermal gd T Cells Are the Major Source of IL-17 upon IL-23 Stimulation in the Skin
To detect IL-17-producing cells in the skin, single-cell suspensions were prepared from both murine epidermis and dermis. The gating strategy is shown in Figure S1 (available online). Epidermal T cells were exclusively gd T cells with high intensity of CD3 and T cell receptor gd (gdTCR) staining and did not produce any appreciable IL-17 in response to IL-23 stimulation ( Figure 2A ). In contrast, dermal T cells were approximately 50% gd and 50% ab T cells with intermediate intensity of CD3 and gdTCR staining, and IL-17 was mainly secreted by the dermal gd T cells upon IL-23 stimulation (Figure 2A ). Dermal gd T cells constituted approximately 90% of IL-17-producing cells ( Figure 2B ). Minimal IL-17 production was observed from dermal gdTCR-negative T cells ( Figure 2C ). Because skin cell preparations contain many other cell subsets, dermal CD3 + TCRgd + T cells and CD3 + TCRgd À T cells were sorted and stimulated with IL-23 alone or in combination with IL-1b. As depicted in Figure 2D , IL-23 or IL-1b alone could not stimulate dermal gd T cells for IL-17 production. However, the combination of IL-23 and IL-1b stimulated dermal gd T cells to produce large amounts of IL-17. Dermal gdTCR À T cells also secreted detectable IL-17 upon IL-23 and IL-1b stimulation but the concentration was 10-fold lower compared to dermal gd T cells. The requirement of IL-1b for IL-23-induced skin dermal gd T cell IL-17 production was further confirmed by using neutralizing IL-1b mAb and IL-1 receptor type I-deficient (Il1r1 À/À ) mouse skin cells ( Figure 2E ).
Collectively, these data suggest that, in mice, dermal gd T cells are the major IL-17-producing cells in the skin in response to IL-23 stimulation and that the production of IL-17 by dermal gd T cells requires endogenous IL-1b.
IL-17-Producing Dermal gd T Cells Are Phenotypically Unique gd T cells accounted for 0.5%-1% of total dermal cells in naive C57BL/6 mouse skin. To determine whether dermal gd T cells used a unique gdTCR, we measured the TCR Vg usage by using a panel of antibodies specific for various Vg TCR segments including Vg1, Vg4, Vg5, Vg6, and Vg7 (Heilig and Tonegawa, 1986) . As depicted in Figure 3A , a fraction of dermal gd T cells expressed Vg4 whereas epidermal gd T cells expressed exclusively Vg5 and partly cross-reacted with Vg6 antibody (Roark et al., 2004) . Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis revealed that dermal gd T cells could also use a Vg2 gene segment ( Figure S2C ). Consistent with previous results (Born et al., 2010) , splenic gd T cells preferentially expressed Vg1 and Vg4 and both were capable of producing IL-17 ( Figure S2B ). In addition, approximately 50% of IL-17-producing dermal gd T cells expressed Vg4 ( Figure 3B ). To further delineate the role of Vg4 T cells in skin IL-17 production, mice were injected with Vg4-depleting mAb. We found that IL-17 production from dermal gd T cells was significantly decreased after Vg4 T cell depletion ( Figure 3C ). The chemokine receptor CCR6 and transcriptional factor RORgt are associated with the development and recruitment of CD4 + Th17 cells and are also expressed on splenic gd T cells (Martin et al., 2009) . We found that dermal gd T cells, but not epidermal gd T cells, constitutively expressed CCR6 and RORgt ( Figures 3D and 3E ). We also used real-time PCR to further explore their chemokine receptor mRNA expression profiles and IL-23R expression. As shown in Figure 3F , dermal gd T cells expressed constitutively IL-23R, along with the chemokine receptors CCR1, CCR2, CCR4, CCR5, CCR6, CXCR3, and CXCR4. These findings suggest that dermal gd T cells display a unique TCR Vg usage and chemokine receptor profile with IL-17-producing capability.
CD27 has recently been defined as a critical molecule that differentiates interferon-g (IFN-g)-producing versus IL-17-producing gd T cells (Ribot et al., 2009; Wakita et al., 2010) . Skin dermal and epidermal gd T cells were exclusively CD27 À and did not produce any appreciable IFN-g ( Figure S2D ). In contrast, lymph node (LN) gd T cells have both CD27
+ and CD27 See also Figure S1 .
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Dermal gd T Cells in Skin Inflammation predominant IL-17 producers. In contrast, dermal T cells from Tcrd À/À mice secreted minimal IL-17 ( Figure 4A ). Previous studies demonstrated that autoreactive T cell IL-17 production requires interaction of ab and gd T cells (Cui et al., 2009 ). However, Tcra À/À skin cells produced similar amount of IL-17
( Figure 4A ), predominantly from dermal gd T cells, suggesting that the IL-17 production from dermal gd T cells is independent of ab T cells. IL-23-induced changes in mouse skin share many characteristics with human psoriasis (Chan et al., 2006) . In agreement with a previous report (Chan et al., 2006) , WT mice injected intradermally with IL-23 developed epidermal thickening and massive neutrophil infiltration ( Figure 4B ). These changes were significantly decreased in Tcrd À/À mice but were not significantly altered in Tcra À/À mice ( Figure 4B ). We used real-time PCR on skin tissues to assess the effect of IL-23 on mRNA expression of IL-17, IL-22, TNF-a, IL-6, matrix metalloprotease-9 (MMP-9), and IFN-g. IL-17 and IL-22 mRNAs were significantly increased in WT mice receiving IL-23 injection and both were significantly decreased in Tcrd À/À mice compared to WT mice ( Figure 4C ).
In Tcra À/À mice, IL-17 mRNA was similar to that in WT mice but IL-22 mRNA was significantly lower than that in WT mice ( Figure 4C ). We also examined IL-17 production in skin draining LNs (DLNs) and spleen from these mice to determine IL-23 effect on local and systemic IL-17 production. In skin DLNs, the frequency of IL-17-producing cells was not significantly changed in mice lacking ab or gd T cells upon phorobol myristate acetate (PMA) plus ionomycin stimulation ( Figure 4D ). Both gd and ab (Figures 4E) . Together, these in vivo data corroborate our in vitro observations that IL-23 preferentially promotes IL-17 production from gd T cells. These data further suggest that gd T cells are required for IL-23-induced skin inflammation and acanthosis. Because IMQ-induced psoriasis-like murine model is also mediated by the IL-23-IL-17 axis as described previously (van der Fits et al., 2009 ) as well as demonstrated in our study (Figure 1B) , we examined whether dermal gd T cells are also responsible for skin IL-17 production. Dermal gd T cells spontaneously secreted a large amount of IL-17 in IMQ-treated skin cells (Figure S3A ). In addition, gd T cells were increased in both skin and LNs from IMQ-treated mice and secreted large amount of IL-17. Consistent with the IL-23-injected psoriasis model, the frequency of splenic gd T cells and IL-17 production from gd T cells were not altered. To further assess the role of gd T cells and ab T cells in the IMQ-induced mouse model of psoriasis, WT, Tcra
, and Tcrd À/À mice were treated with or without IMQ cream. WT mice treated with IMQ had significantly increased epidermal hyperplasia and massive neutrophil infiltration ( Figures S3B and S3C) . However, the epidermal thickening and neutrophil infiltration induced by IMQ were significantly decreased in Tcrd À/À mice. In contrast to IL-23-induced skin inflammation, IMQ-induced epidermal hyperplasia was also significantly decreased in Tcra À/À mice ( Figure S3B ). However, neutrophil infiltration induced by IMQ was not significantly different in Tcra À/À mice ( Figure S3C ). Furthermore, real-time PCR analysis revealed that IL-17 mRNA was increased upon IMQ treatment. However, the IL-17 mRNA in Tcrd À/À mice was lower than that in WT mice and Tcra À/À mice (data not shown).
Similarly, IL-22 mRNA was increased after IMQ treatment. There was no difference among WT, Tcra À/À , and Tcrd À/À mice (data not shown). These data suggest that dermal gd T cells are also the major IL-17-producing cells that are critical in an IMQ-induced psoriasis-like model.
IL-17R Expression Is Necessary for IL-23-Induced Epidermal Hyperplasia and Inflammation
The IL-17 cytokine family includes six members, IL-17A to F. IL-17A and IL-17F mediate inflammatory activities via the IL-17R complex, comprised of the IL-17RA and IL-17RC subunits (Gaffen, 2009 ). The IL-17R is expressed ubiquitously in hematopoietic tissues (Yao et al., 1995) as well as in psoriatic lesions (Johansen et al., 2009) . As shown in Figure 5A , the epidermal hyperplasia induced by IL-23 was markedly decreased in Il17ra À/À mice compared to WT mice. Neutrophil infiltration was also significantly decreased in these mice. Real-time PCR indicated that mRNA concentrations of IL-17 and IL-22 were increased upon IL-23 treatment in both WT and Il17ra À/À mice.
The mRNAs of TNF-a, MMP-9, and IFN-g remained unchanged but IL-6 mRNA amount was significantly decreased in Il17ra À/À mice ( Figure 5B ). This suggests that downstream IL-17R signaling is critical in IL-23-induced epidermal hyperplasia.
IL-23 but Not Pathogen Products Stimulates In Vitro Expansion of Dermal gd T Cells
Microbial infection is thought to be important in the initiation of psoriasis (Gudjonsson et al., 2003; Cai et al., 2009 ). Previous studies demonstrated that the TLR2 agonist Pam3CSK4, but not IL-23, stimulates splenic gd T cell expansion in vitro (Reynolds et al., 2010) . We therefore stimulated skin cells with different pathogen products or IL-23. Pam3CSK4 and other pathogen products alone did not stimulate dermal gd T cell proliferation ( Figure 6A and data not shown). However, IL-23 alone was found to be sufficient for driving dermal gd T cell proliferation, but not for dermal gd À T cells or epidermal gd T cells (Figure 6A ). In contrast, Pam3CSK4, but not IL-23, stimulated splenic gd T cell proliferation ( Figure S4 ), consistent with a previous report (Reynolds et al., 2010) . These data suggest that IL-23 is essential for both maintaining dermal gd T cell homeostasis and regulating its differentiation program. We next examined the effect of these pathogen products on dermal gd T cell IL-17 production. TLR agonists Pam3CSK4 (TLR2), Gardiquimod (TLR7), and CpG (TLR9) but not lipopolysaccharide (LPS) (TLR4) or dectin-1 ligand curdlan (LeibundGut-Landmann et al., 2007) stimulated dermal gd T cells to produce low amount of IL-17 as assessed by intracellular cytokine staining ( Figure 6B ). Combining pathogenic products with IL-23 did not increase the percentage of IL-17-producing cells. However, the mean fluorescent intensity of IL-17 production was increased. Furthermore, a synergistic effect on IL-17 production as assessed by ELISA was observed when cells were exposed to both IL-23 and pathogen products ( Figure 6C ). IL-17 production by gd T cells from the peritoneum, lungs, and 
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Dermal gd T Cells in Skin Inflammation spleen requires both IL-23 and IL-1b stimulation (Duan et al., 2010; Sutton et al., 2009) . Similarly, IL-17 production from dermal gd T cells was completely abrogated in Il1r1 À/À mice (Figure 6D) , suggesting that the IL-1R signaling pathway is essential for pathogen product-mediated IL-17 production in skin.
Large Numbers of IL-17-Secreting gd T Cells in Human Psoriatic Skin We next examined dermal gd T cells in lesions from patients with psoriasis. Unlike the case in murine skin, gd T cells do not exist in human epidermis but approximately 4% of human dermal leukocytes are CD3 + gdTCR + T cells (Ebert et al., 2006) . We found that CD3 + T cells were significantly increased in psoriatic lesions whereas CD3 + T cells were scarce in healthy control skins (Figure 7A ). In addition, the frequency of gd T cells in dermis was significantly increased in patients with psoriasis compared to healthy controls ( Figure 7A ). Confocal microscopy analysis revealed that infiltration of gd T cells was readily seen in the dermis of psoriatic skin lesions ( Figure 7B ). We further analyzed IL-17 production from these cells. Healthy control dermal gd T cells produced minimal IL-17 even when these cells were stimulated with IL-23, probably because of lower or absent endogenous IL-1b (Kryczek et al., 2008) . In contrast, approximately 15% of gd T cells in psoriatic lesions produced IL-17 upon IL-23 stimulation ( Figure 7C ). Furthermore, the percentage of gd T cells secreting IL-17 was significantly higher than that of gd These data demonstrate that dermal gd T cells in patients with psoriasis are greatly increased and produce substantial amounts of IL-17.
DISCUSSION
Our results demonstrate that murine innate dermal gd T cells are the major source of IL-17 upon IL-23 stimulation in skin and that these cells constitutively express RORgt, IL-23R, CCR6, and other chemokine receptors. Furthermore, in mice, IL-17 production by dermal gd T cells appears to be independent of ab T cells. Importantly, IL-23-induced skin inflammation and acanthosis are significantly attenuated in Tcrd À/À mice and Il17ra À/À mice. In addition, IMQ-induced skin inflammation and epidermal hyperplasia are also significantly decreased in Tcrd À/À mice. In vitro, IL-23 preferentially stimulates dermal gd T cell proliferation, suggesting a possible feed-forward mechanism in the pathogenesis of psoriasis. Finally, in both mice and humans, dermal gd T cells are critical IL-17-producing cells in the genesis of psoriasis. A major role of IL-23 in autoimmunity is thought to be promotion of Th17 cell expansion and survival (Kikly et al., 2006) . A recent study reveals that IL-23 together with IL-1b activates splenic gd T cells to produce IL-17 (Sutton et al., 2009 ). Microbiota also regulate the production of IL-17 from gd T cells (Duan et al., 2010) . IL-23 has a central role in the pathogenesis of psoriasis Lee et al., 2004) . The cellular sources of IL-23 in skin are mainly infiltrating DCs and monocytes in the dermis (Lee et al., 2004; Wilson et al., 2007) , with keratinocytes and Langerhans cells in the epidermis (Aliahmadi et al., 2009; Piskin et al., 2006) . We found that IL-23 is mainly secreted by skin-infiltrating DCs and Mf in both human psoriatic skin and IMQ-induced mouse psoriatic skin lesions. IL-23 not only promoted IL-17 production by dermal gd T cells that was irrespective of gdTCR stimuli but also drove their in vitro expansion. IL-17 production by dermal gd T cells required endogenous IL-1b as shown by the fact that sorted dermal gd T cells could not secrete IL-17 upon stimulation with IL-23 alone. However, psoriatic skin keratinocytes and infiltrating inflammatory cells do secrete elevated amounts of IL-1b (Yoshinaga et al., 1995) . IL-1b treatment results in an upregulation of tight junction (TJ) proteins occludin and ZO-1, which resembles TJ protein alteration in early psoriasis (Kirschner et al., 2009 ). Thus, skin dermal gd T cells, as well as gd T cells from spleen, LNs, lungs, and peritoneum (Duan et al., 2010; Sutton et al., 2009 ), require both IL-23 and IL-1b cytokines for IL-17 production.
The dermal IL-17-producing gd T cells share many characteristics with other IL-17-producing cell subsets (Hedrick et al., 2009) , including constitutive expression of RORgt, CCR6, and IL-23R. The dermal gd T cells also constitutively express a number of chemokine receptors including CCR1, CCR2, CCR4, CCR5, CXCR3, and CXCR4, which may be involved in their trafficking. In addition, dermal gd T cells express lower intensity of CD3 and gdTCR as compared to epidermal gd T cells. It is worth noting that there is a small percentage of a CD3 hi population existing in the dermal preparations. These CD3 hi gd T dermal cells are probably contaminating epidermal gd T cells because they express a unique Vg5 (data not shown) gene segment, which is a hallmark of epidermal gd T cells. However, it is also possible that these cells are bona fide dermal residents. Compared to the previous studies indicating that gd T cells expressing Vg1 and Vg4 gene segments are predominantly IL-17-producing gd T cells (Cui et al., 2009; Martin et al., 2009) , we found that the dominant dermal IL-17-producing gd T cells are Vg4 + because depletion of Vg4 T cells in the skin significantly decreased IL-17 production from dermal gd T cells. We also found that dermal gd T cells express the Vg2 gene segment. Although dermal gd T cells share many features See also Figure S3 . 
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Immunity 35, 1-15, October 28, 2011 ª2011 Elsevier Inc. 11 the in vitro expansion of dermal gd T cells whereas IL-23 has no effect on splenic gd T cell proliferation (Reynolds et al., 2010) . The pathogenic importance of gd T cell response in murine psoriasis models is emphasized by significant decreases of acanthosis and skin inflammation in Tcrd À/À mice. In contrast, Tcra À/À mice respond to IL-23 just as do WT mice, and dermal gd T cells from Tcra À/À mice produce similar amounts of IL-17.
Consistent with in vitro data, Tcrd À/À mice have lower IL-17 mRNA. Notably, IL-22 mRNA in Tcra À/À mice was lower than in WT mice, yet these mice still developed acanthosis and skin inflammation. It is possible that the IL-22 concentration in Tcra À/À mice, although low, is sufficient to induce biological effects. Alternatively, IL-22 may not be absolutely required for IL-23-induced skin inflammation and acanthosis. This notion is further supported by the observation in Il17ra À/À mice in which IL-22 mRNA was increased upon IL-23 injection but acanthosis and skin inflammation were completely abrogated. It is worth noting that Tcrd À/À mice did show minor epidermal hyperplasia and neutrophil infiltration compared to PBS-treated WT mice. This may be related to the IL-23-mediated T cell-independent inflammatory process (Buonocore et al., 2010; Hedrick et al., 2009 ). In the current study, we also observed that the epidermal hyperplasia induced by IL-23 was completely abrogated in Il17ra À/À mice despite similar IL-17 mRNA amount, whereas an earlier report indicated that IL-23-induced acanthosis was independent of IL-17A (Chan et al., 2006) . A recent study using both Il17a À/À mice and neutralizing IL-17A mAb clearly demonstrated that IL-17A is a pathogenic cytokine in IL-23-induced skin inflammation and acanthosis (Rizzo et al., 2011) . In addition, an initial phase II double-blind, randomized trial has demonstrated the therapeutic efficacy of a fully human IL-17A mAb (AIN457) in psoriasis treatment (Miossec et al., 2009) . We further demonstrated that dermal gd T cells secreted large amount of IL-17 in an IMQ-induced psoriasis model. IMQ cream topical treatment induces exacerbated psoriasis in patients with a well-controlled psoriasis pathology (Rajan and Langtry, 2006 T cells also play a critical role in natural stimuli-induced psoriasis. These data also suggest that the roles of IL-17, IL-22, gd T cells, and ab T cells may vary in their degree of contribution to skin pathology depending on whether IL-23 or IMQ is used to induce skin inflammation.
In support of possible bacterial initiation of psoriasis, we did find that pathogen products have a stimulatory effect on dermal gd T cell IL-17 production. TLR and dectin-1 ligands promoted IL-17 production from dermal gd T cells in combination with IL-23. The synergistic effect was dependent on the IL-1R signaling pathway. CD44 hi CCR6
+ gd T cells express TLR1, TLR2, and dectin-1 (Martin et al., 2009) ; thus, these pathogen products may directly stimulate dermal gd T cells to produce IL-17. In addition, pathogen products may stimulate IL-1b production that synergizes with IL-23 to induce potent IL-17 production. Although IL-23-or IMQ-induced psoriasis-like skin lesions in mice share some clinical and histological characteristics with human psoriasis (Chan et al., 2006) , there are differences. Most notably, human skin does not have DETCs whereas T cells bearing abTCR exist predominantly in human dermis. Thus, the importance of dermal gd T cells as the major IL-17-producing T cells needs to be tested in human psoriasis patients. In healthy controls, CD3 + T cells are scarce and are predominantly ab T cells. gd T cells constitute only 5%-10% of total dermal leukocytes. We found that gd T cells were significantly increased in psoriatic skin consistent with a previous pathology report (Seung et al., 2007) . In addition, both percentage and absolute numbers of IL-17-producing gd T cells were significantly more than those of gd À T cells. The increased gd T cell infiltration implies that these cells may expand locally. Alternatively, these gd T cells may also migrate from the periphery into the skin dermis via chemotaxis. Local chemokine CCL20 production is also increased in psoriatic skin (Kryczek et al., 2008) . Although gd T cells are conventionally considered to be innate immune cells that provide early and rapid responses including high amounts of effector cytokines such as IFN-g and IL-17 in the models of infection, tumor, and exposure to injury (Gao et al., 2003; Hamada et al., 2008; Matsubara et al., 2009) , the increased frequency of dermal gd T cells in psoriatic skin suggests that gd T cells are also crucial in the form of chronic inflammation. This may be not very surprising because marked expansion of gd T cells occurs in relatively late stages of infection and chronic inflammation (Roark et al., 2007; Simonian et al., 2006) . Thus, dermal gd T cells may engage in immune responses both early and late. Taken together, our results emphasize the importance of dermal gd T cells on innate IL-17 production. Dermal gd T cells represent a major source of IL-17 that promotes the development and progression of skin inflammation such as psoriasis.
, and Il1r1 À/À mice on C57BL/6 background were purchased from Jackson Laboratory. C57BL/6 Tcrd À/À mice do not have dermatitis (Girardi et al., 2002) . Il17ra À/À mice have been previously described (Ye et al., 2001 ). All animals were housed and treated in accordance with institutional guidelines and approved by the IACUC at the University of Louisville.
Human Subjects
Patients with psoriasis vulgaris were diagnosed based on the clinical and histopathologic criteria. Skin biopsies were collected from the lesional site of 12 patients and 6 normal volunteers. All patients had not been treated on systemic therapy for at least 4 weeks prior to the study entry. The study was approved by the Shanghai Jiaotong University School of Medicine Research Ethics Committee. All the participants gave their written informed consent.
Skin Cell Preparation and Stimulation
Mouse back skin or human skin was incubated in dispase to separate epidermis and dermis. Epidermal cell suspensions were prepared by
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Dermal gd T Cells in Skin Inflammation incubating epidermis with trypsin-EDTA. A buffer containing collagenase IV, hyaluronidase, and DNase-I was used to obtain dermal cell suspensions. Mouse cells were stimulated with varying concentrations of mouse rIL-23 (eBioscience), 100 ng/ml LPS, 1 mg/ml Pam3CSK4, 50 mg/ml Curdlan, 1 mg/ml Gardiquimod, or 0.5 mg/ml CpG for 2 days. The supernatants were harvested for IL-17 measurement by ELISA (Biolegend). Cells were also stimulated with IL-23 (50 ng/ml) for 18 hr in the presence of GolgiPlug (BD Bioscience) for intracellular IL-17 staining. In IL-1b blocking experiment, neutralizing IL-1b mAb (2 mg/ml, eBioscience) or isotype mAb was added in the culture before IL-23 stimulation. Additionally, skin DCs and Mf were purified from whole skin cells by positive selection with anti-mouse CD11c and CD11b microbeads (Miltenyi Biotec). Whole skin cells, skin cells devoid of DCs and Mf, or purified skin DCs and Mf were stimulated with IMQ (2 mg/ml) at different time points. For human studies, dermal cells were stimulated with human rIL-23 (100 ng/ml) for 18 hr in the presence of GolgiPlug for intracellular IL-17 staining. To calculate the absolute numbers of IL-17-producing cells, we used the following formula: absolute IL-17-producing cell numbers = % of CD3 + cells 3 % of gd + or gd À T cells 3 % of IL-17-positive cells 3 total cell numbers. To normalize the baselines for all samples, we used per million cells as baseline.
Flow Cytometry Analysis and Intracellular Staining
Mouse bTCR, CD3, and IL-17A mAbs were obtained from BD Biosciences. Mouse gdTCR, RORgt, and CD27 and human gdTCR, CD3, and IL-17A mAbs were purchased from eBioscience. Mouse CCR6, IL-22 mAbs were obtained from R&D system. All mouse TCR Vg antibodies were kindly provided by R. O'Brien (National Jewish Health, Denver, CO). For intracellular staining, cells were first stained with different cell surface Abs and then fixed, permeabilized, and stained intracellularly for IL-17, IL-22, TNF-a, IFN-g, or RORgt. The relevant isotype control mAbs were also used. Samples were harvested with a BD FACS Calibur and analyzed with FlowJo software (TreeStar).
Cell Sorting
The whole skin cell suspensions were stained with mouse CD3 and gdTCR mAbs. Epidermal and dermal gd T cells were sorted by MoFlow high-speed sorter. In addition, dermal cell suspensions were stained with mouse CD3 and gdTCR mAbs and dermal gd + and gd À T cells were sorted.
In Vivo Mouse Vg4 T Cell Depletion Mouse Vg4 Ab (250 mg) or isotype control mAb was intravenously injected into mice for 3 days. Mice were sacrificed and dermal cell suspensions were stimulated with IL-23 for intracellular IL-17 staining.
Establishment of Psoriasis-like Mouse Models IL-23-induced psoriasis-like mouse model was established as previously described (Chan et al., 2006) . In brief, IL-23 (1 mg) or vehicle control was daily intradermally injected on the back skin of WT, Tcrd
, or Il17ra À/À mice for 4 days. IMQ-induced psoriasis-like model was described previously (van der Fits et al., 2009 ). Mice were treated with a daily topical dose of commercially available IMQ cream (5%) (Aldara; 3M Pharmaceuticals) on the shaved back for 3 or 5 consecutive days. Mice were sacrificed and the skin samples were embedded and froze in OCT for H&E and immunohistochemistry (IHC) staining. In some experiments, skin DLNs and spleens were also isolated for intracellular cytokine staining.
Skin Histology and IHC Staining
Skin sections were stained with H&E and the epidermal thickness was determined by measuring the average interfollicular distance under the microscope in a blinded manner. For IHC staining, skin cryosections were fixed, blocked, and then stained with rat-anti-mouse Gr-1 followed by goat-anti-rat IgG secondary Ab (Southern Biotech). Slides were developed with 3-amino-9-ethylcarbazole (AEC) substrate solution (Vector Laboratories) and then counterstained with hematoxylin. Images were acquired at 3200 magnification with Aperio ScanScope digital scanners and Gr-1 expression was quantitatively analyzed as mean intensity with Image-pro software (Media Cybernetics Inc.).
Immunofluorescence Staining
Human skin samples were fixed, cryosectioned, blocked, and then stained with the following primary Abs: mouse anti-human gdTCR and CD3 (eBioscience), rabbit anti-human or mouse IL-23p19 (Abcam), and biotinylated mouse antihuman CD11c (eBioscience) or CD68 (Biolegend). For mouse skin samples, frozen sections were stained with primary Abs of rabbit anti-human or mouse IL-23p19 (Abcam) and APC-hamster anti-mouse CD11c (eBioscience) or APC-rat anti-mouse F4/80 (eBioscience). Images were acquired by Leica TCS SP5 confocal microscope system.
RNA Extraction and Real-Time Quantitative PCR
RNAs were isolated with a QIAGEN RNeasy kit (QIAGEN). After reverse transcription into cDNA with a Reverse Transcription Kit (Bio-Rad), qPCR was then performed on MyiQ single color RT-PCR detection system with SYBR Green Supermix (Bio-Rad) and gene-specific primers were summarized in Table S1 . We normalized gene expression amount to b-2 microglobulin (b-MG) housekeeping gene and represented data as fold differences by the 2 ÀDDCt method, where DCt = Ct target gene À Ct b-MG and DDCt = DCt induced À DCt reference .
Statistical Analysis
All quantitative data are shown as mean ± SEM unless otherwise indicated. 
